October 1, 2018

Ned Milenkovich, co-chair of the firm's Health Care practice, authored an article for Pharmacy Times that analyzes the responsibilities of pharmacists to prevent the diversion of controlled substances. He identifies best practices for ensuring that a prescribed narcotic regimen is being used for legitimate medical purposes and summarizes key requirements under U.S. Drug Enforcement Administration regulations.

This article contains material of general interest and should not be construed as legal advice or a legal opinion on any specific facts or circumstances. Under applicable rules of professional conduct, this content may be regarded as attorney advertising.